nature.com search

Loading Filters

Showing 1–32 of 32 results

Loading Filters

Research | 30 July 2020
Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality
- A. Sutra Del Galy
- , A. Marouf
- , E. Raffoux
- , M. Robin
- , D. Michonneau
- , M. Sébert
- , F. Sicre de Fontebrune
- , A. Xhaard
- , E. Lengline
- , R. Itzykson
- , C. Frieri
- , H. Dombret
- , P. Fenaux
- , R. Peffault de Latour
- , L. Adès
- & G. Socié
Leukemia 35 , 225–228

Rights & permissionsfor article Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality . Opens in a new window.
Research | 20 July 2020
Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study
- Matthieu Jestin
- , Sihem Tarfi
- , Matthieu Duchmann
- , Bouchra Badaoui
- , Nicolas Freynet
- , Violaine Tran Quang
- , Ivan Sloma
- , Nathalie Droin
- , Margot Morabito
- , Mathieu Leclerc
- , Sébastien Maury
- , Pierre Fenaux
- , Eric Solary
- , Dorothée Selimoglu-Buet
- , Orianne Wagner-Ballon
- , P. Fenaux
- , N. Vey
- , L. Adès
- , A. Guerci
- , F. Chermat
- , M. Fontenay
- , S. Raynaud
- , C. Preudhomme
- , E. Solary
- , T. Braun
- , O. Beynerauzy
- , R. Itzykson
- , S. Park
- , O. Kosmider
- , T. Cluzeau
- & A. Renneville
Leukemia , 1–4

Rights & permissionsfor article Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study . Opens in a new window.
Research | 18 September 2020 | Open
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
- Marlijn Hoeks
- , Tim Bagguley
- , Corine van Marrewijk
- , Alex Smith
- , David Bowen
- , Dominic Culligan
- , Seye Kolade
- , Argiris Symeonidis
- , Hege Garelius
- , Michail Spanoudakis
- , Saskia Langemeijer
- , Rian Roelofs
- , Erwin Wiegerinck
- , Aurelia Tatic
- , Sally Killick
- , Panagiotis Panagiotidis
- , Oana Stanca
- , Eva Hellström-Lindberg
- , Jaroslav Cermak
- , Melanie van der Klauw
- , Hanneke Wouters
- , Marian van Kraaij
- , Nicole Blijlevens
- , Dorine W. Swinkels
- , Theo de Witte
- , R. Stauder
- , A. Walder
- , M. Pfeilstöcker
- , A. Schoenmetzler-Makrai
- , S. Burgstaller
- , J. Thaler
- , I. Mandac Rogulj
- , M. Krejci
- , J. Voglova
- , P. Rohon
- , A. Jonasova
- , J. Cermak
- , D. Mikulenkova
- , I. Hochova
- , P. D. Jensen
- , M. S. Holm
- , L. Kjeldsen
- , I. H. Dufva
- , H. Vestergaard
- , D. Re
- , B. Slama
- , P. Fenaux
- , B. Choufi
- , S. Cheze
- , D. Klepping
- , B. Salles
- , B. de Renzis
- , L. Willems
- , D. De Prost
- , J. Gutnecht
- , S. Courby
- , V. Siguret
- , G. Tertian
- , L. Pascal
- , M. Chaury
- , E. Wattel
- , A. Guerci
- , L. Legros
- , P. Fenaux
- , R. Itzykson
- , L. Ades
- , F. Isnard
- , L. Sanhes
- , R. Benramdane
- , A. Stamatoullas
- , S. Amé
- , O. Beyne-Rauzy
- , E. Gyan
- , U. Platzbecker
- , C. Badrakan
- , U. Germing
- , M. Lübbert
- , R. Schlenk
- , I. Kotsianidis
- , C. Tsatalas
- , V. Pappa
- , A. Galanopoulos
- , E. Michali
- , P. Panagiotidis
- , N. Viniou
- , A. Katsigiannis
- , P. Roussou
- , E. Terpos
- , A. Kostourou
- , Z. Kartasis
- , A. Pouli
- , K. Palla
- , V. Briasoulis
- , E. Hatzimichael
- , G. Vassilopoulos
- , A. Symeonidis
- , A. Kourakli
- , P. Zikos
- , A. Anagnostopoulos
- , M. Kotsopoulou
- , K. Megalakaki
- , M. Protopapa
- , E. Vlachaki
- , P. Konstantinidou
- , G. Stemer
- , A. Nemetz
- , U. Gotwin
- , O. Cohen
- , M. Koren
- , E. Levy
- , U. Greenbaum
- , S. Gino-Moor
- , M. Price
- , Y. Ofran
- , A. Winder
- , N. Goldshmidt
- , S. Elias
- , R. Sabag
- , I. Hellman
- , M. Ellis
- , A. Braester
- , H. Rosenbaum
- , S. Berdichevsky
- , G. Itzhaki
- , O. Wolaj
- , S. Yeganeh
- , O. Katz
- , K. Filanovsky
- , N. Dali
- , M. Mittelman
- , L. Malcovati
- , L. Fianchi
- , A. vd Loosdrecht
- , V. Matthijssen
- , A. Herbers
- , H. Pruijt
- , N. Aboosy
- , F. de Vries
- , G. Velders
- , E. Jacobs
- , S. Langemeijer
- , M. MacKenzie
- , C. Lensen
- , P. Kuijper
- , K. Madry
- , M. Camara
- , A. Almeida
- , G. Vulkan
- , O. Stanca Ciocan
- , A. Tatic
- , A. Savic
- , C. Pedro
- , B. Xicoy
- , P. Leiva
- , J. Munoz
- , V. Betes
- , C. Benavente
- , M. Lozano
- , M. Martinez
- , P. Iniesta
- , T. Bernal
- , M. Diez Campelo
- , D. Tormo
- , R. Andreu Lapiedra
- , G. Sanz
- , E. Hesse Sundin
- , H. Garelius
- , C. Karlsson
- , P. Antunovic
- , A. Jönsson
- , L. Brandefors
- , L. Nilsson
- , P. Kozlowski
- , E. Hellstrom-Lindberg
- , M. Grövdal
- , K. Larsson
- , J. Wallvik
- , F. Lorenz
- , E. Ejerblad
- , D. Culligan
- , C. Craddock
- , S. Kolade
- , P. Cahalin
- , S. Killick
- , S. Ackroyd
- , C. Wong
- , A. Warren
- , M. Drummond
- , C. Hall
- , K. Rothwell
- , S. Green
- , S. Ali
- , D. Bowen
- , M. Karakantza
- , M. Dennis
- , G. Jones
- , J. Parker
- , A. Bowen
- , R. Radia
- , E. Das-Gupta
- , P. Vyas
- , E. Nga
- , D. Creagh
- , J. Ashcroft
- , J. Mills
- & L. Bond
Leukemia , 1–6

Rights & permissionsfor article Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome . Opens in a new window.
Research | 2 June 2017 | Open
Preclinical modeling of myelodysplastic syndromes
- K Rouault-Pierre
- , S A Mian
- , M Goulard
- , A Abarrategi
- , A Di Tulio
- , A E Smith
- , A Mohamedali
- , S Best
- , A-M Nloga
- , A G Kulasekararaj
- , L Ades
- , C Chomienne
- , P Fenaux
- , C Dosquet
- , G J Mufti
- & D Bonnet
Leukemia 31 , 2702–2708

Rights & permissionsfor article Preclinical modeling of myelodysplastic syndromes . Opens in a new window.
11 December 2015 | Open
pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice
- S Patel
- , L Guerenne
- , P Gorombei
- , N Omidvar
- , M-H Schlageter
- , A A Alex
- , S Ganesan
- , R West
- , L Adès
- , V Mathews
- , P Krief
- , M Pla
- , P Fenaux
- , C Chomienne
- & R A Padua
Blood Cancer Journal 5 , e374–e374

Rights & permissionsfor article pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice . Opens in a new window.
19 November 2015
Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine
- J Desoutter
- , J Gay
- , C Berthon
- , L Ades
- , B Gruson
- , S Geffroy
- , I Plantier
- , A Marceau
- , N Helevaut
- , J Fernandes
- , M Bemba
- , L Stalnikiewicz
- , C Frimat
- , J Labreuche
- , O Nibourel
- , C Roumier
- , M Figeac
- , P Fenaux
- , B Quesnel
- , A Renneville
- , A Duhamel
- & C Preudhomme
Leukemia 30 , 1416–1418

Rights & permissionsfor article Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine . Opens in a new window.
21 August 2014
Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients
- R Rahmé
- , X Thomas
- , C Recher
- , N Vey
- , J Delaunay
- , E Deconinck
- , P Hirsch
- , D Bordessoule
- , J-B Micol
- , A Stamatoullas
- , C Mariette
- , C Pautas
- , P Bories
- , J-P Marolleau
- , M Hunault-Berger
- , N Fegueux
- , E Raffoux
- , H Dombret
- , L Degos
- , P Fenaux
- & L Adès
Leukemia 28 , 2422–2424

Rights & permissionsfor article Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients . Opens in a new window.
Research | 15 April 2013
Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS
- M Robin
- , R Porcher
- , L Adès
- , N Boissel
- , E Raffoux
- , A Xhaard
- , J Larghero
- , C Gardin
- , C Himberlin
- , A Delmer
- , P Fenaux
- , H Dombret
- , G Socié
- & R Peffault de Latour
Bone Marrow Transplantation 48 , 1296–1301

Rights & permissionsfor article Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS . Opens in a new window.
Research | 13 February 2015
HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM
- M Robin
- , R Porcher
- , L Adès
- , E Raffoux
- , M Michallet
- , S François
- , J-Y Cahn
- , A Delmer
- , E Wattel
- , S Vigouroux
- , J-O Bay
- , J Cornillon
- , A Huynh
- , S Nguyen
- , M-T Rubio
- , L Vincent
- , N Maillard
- , A Charbonnier
- , R P de Latour
- , O Reman
- , H Dombret
- , P Fenaux
- & G Socié
Leukemia 29 , 1496–1501

Rights & permissionsfor article HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM . Opens in a new window.
Research | 28 January 2015
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet
- E Lengfelder
- , F Lo-Coco
- , L Ades
- , P Montesinos
- , D Grimwade
- , B Kishore
- , S M Ramadan
- , M Pagoni
- , M Breccia
- , A J G Huerta
- , A M Nloga
- , J D González-Sanmiguel
- , A Schmidt
- , J-F Lambert
- , S Lehmann
- , E Di Bona
- , B Cassinat
- , W-K Hofmann
- , D Görlich
- , M-C Sauerland
- , P Fenaux
- & M Sanz
Leukemia 29 , 1084–1091

Rights & permissionsfor article Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet . Opens in a new window.
18 June 2013
Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
- O Kosmider
- , R Itzykson
- , V Chesnais
- , T Lasho
- , R Laborde
- , R Knudson
- , A Gauthier
- , J Merlevede
- , L Ades
- , M Morabito
- , M Fontenay
- , A Tefferi
- , N Droin
- & E Solary
Leukemia 27 , 1946–1949

Rights & permissionsfor article Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia . Opens in a new window.
Research | 22 September 2014
Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML
- M Sébert
- , R Porcher
- , M Robin
- , L Adès
- , N Boissel
- , E Raffoux
- , A Xhaard
- , N Dhedin
- , J Larghero
- , C Himberlin
- , A Delmer
- , P Fenaux
- , H Dombret
- , G Socié
- & R P de Latour
Bone Marrow Transplantation 50 , 74–81

Rights & permissionsfor article Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML . Opens in a new window.
4 May 2012 | Open
Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN?
- E Kouroupi
- , J-J Kiladjian
- , C Dosquet
- , M-L Menot
- , N Bonnin
- , L Ades
- , W Vainchenker
- , C Chomienne
- & B Cassinat
Blood Cancer Journal 2 , e70–e70

Rights & permissionsfor article Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN? . Opens in a new window.
2 April 2012
Hepatic GVHD leading to cirrhosis after allogeneic hematopoietic SCT
- A Xhaard
- , P Nahon
- , M Robin
- , C Baudry
- , L Ades
- , R Peffault de Latour
- & G Socié
Bone Marrow Transplantation 47 , 1484–1485

Rights & permissionsfor article Hepatic GVHD leading to cirrhosis after allogeneic hematopoietic SCT . Opens in a new window.
31 August 2009
Efficacy of lenalidomide in an sAML patient with del 5q relapsing after reduced-intensity allogeneic stem cell transplantation performed in complete remission
- L Adès
- , V Eclache
- , C Gardin
- , S Boehrer
- , G Leroux
- , P Martiat
- & P Fenaux
Bone Marrow Transplantation 45 , 791–792

Rights & permissionsfor article Efficacy of lenalidomide in an sAML patient with del 5q relapsing after reduced-intensity allogeneic stem cell transplantation performed in complete remission . Opens in a new window.
5 April 2011
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
- R Itzykson
- , S Thépot
- , V Eclache
- , B Quesnel
- , F Dreyfus
- , O Beyne-Rauzy
- , P Turlure
- , N Vey
- , C Recher
- , S Boehrer
- , C Gardin
- , L Adès
- & P Fenaux
Leukemia 25 , 1207–1209

Rights & permissionsfor article Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine . Opens in a new window.
Research | 19 April 2010
Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
- L Karlin
- , B Arnulf
- , S Chevret
- , L Ades
- , M Robin
- , R P De Latour
- , M Malphettes
- , N Kabbara
- , B Asli
- , V Rocha
- , J P Fermand
- & G Socie
Bone Marrow Transplantation 46 , 250–256

Rights & permissionsfor article Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy . Opens in a new window.
Research | 15 April 2011
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
- R Itzykson
- , O Kosmider
- , T Cluzeau
- , V Mansat-De Mas
- , F Dreyfus
- , O Beyne-Rauzy
- , B Quesnel
- , N Vey
- , V Gelsi-Boyer
- , S Raynaud
- , C Preudhomme
- , L Adès
- , P Fenaux
- & M Fontenay
Leukemia 25 , 1147–1152

Rights & permissionsfor article Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias . Opens in a new window.
Research | 8 January 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases
- R Itzykson
- , S Ayari
- , D Vassilief
- , E Berger
- , B Slama
- , N Vey
- , F Suarez
- , O Beyne-Rauzy
- , A Guerci
- , S Cheze
- , X Thomas
- , A Stamatoullas
- , M Gardembas
- , F Bauduer
- , A Kolb
- , M C Chaury
- , L Legros
- , G Damaj
- , F Chermat
- , F Dreyfus
- , P Fenaux
- & L Ades
Leukemia 23 , 673–678

Rights & permissionsfor article Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases . Opens in a new window.
16 March 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)
- C Kelaidi
- , L Ades
- , S Chevret
- , M Sanz
- , A Guerci
- , X Thomas
- , S de Botton
- , E Raffoux
- , C Rayon
- , N Fegueux
- , D Bordessoule
- , F Rigal-Huguet
- , H Link
- , A Stoppa
- , A Vekhoff
- , S Meyer-Monard
- , S Castaigne
- , H Dombret
- , L Degos
- & P Fenaux
Leukemia 20 , 905–907

Rights & permissionsfor article Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials) . Opens in a new window.
Research | 27 June 2005
Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders
- H Bittencourt
- , V Rocha
- , A Filion
- , I Ionescu
- , A-L Herr
- , F Garnier
- , L Ades
- , H Esperou
- , A Devergie
- , P Ribaud
- , G Socie
- & E Gluckman
Bone Marrow Transplantation 36 , 431–435

Rights & permissionsfor article Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders . Opens in a new window.
Research | 9 September 2010
The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation
- S Thepot
- , J Zhou
- , A Perrot
- , M Robin
- , A Xhaard
- , R P de Latour
- , L Ades
- , P Ribaud
- , A D Petropoulou
- , R Porcher
- & G Socié
Leukemia 24 , 1852–1858

Rights & permissionsfor article The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation . Opens in a new window.
Research | 16 October 2006
Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia
- G Carvalho
- , C Fabre
- , T Braun
- , J Grosjean
- , L Ades
- , F Agou
- , E Tasdemir
- , S Boehrer
- , A Israel
- , M Véron
- , P Fenaux
- & G Kroemer
Oncogene 26 , 2299–2307

Rights & permissionsfor article Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia . Opens in a new window.
25 November 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
- L Ades
- , S Chevret
- , S De Botton
- , X Thomas
- , H Dombret
- , B Beve
- , M Sanz
- , A Guerci
- , J S Miguel
- , J dela Serna
- , C Garo
- , A M Stoppa
- , O Reman
- , A Stamatoulas
- , M Fey
- , J Y Cahn
- , J J Sotto
- , J H Bourhis
- , A Parry
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 19 , 230–233

Rights & permissionsfor article Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience . Opens in a new window.
Research | 24 November 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
- S de Botton
- , M A Sanz
- , S Chevret
- , H Dombret
- , G Martin
- , X Thomas
- , J D Mediavilla
- , C Recher
- , L Ades
- , B Quesnel
- , P Brault
- , M Fey
- , H Wandt
- , D Machover
- , A Guerci
- , F Maloisel
- , A M Stoppa
- , C Rayon
- , J M Ribera
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 20 , 35–41

Rights & permissionsfor article Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy . Opens in a new window.
Research | 16 January 2013
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents
- C Kelaidi
- , S Park
- , R Sapena
- , O Beyne-Rauzy
- , V Coiteux
- , N Vey
- , A Stamatoullas
- , B Choufi
- , J Delaunay
- , M-P Gourin
- , S Cheze
- , C Ravoet
- , A Ferrant
- , M Escoffre-Barbe
- , L Aljassem
- , E Raffoux
- , R Itzykson
- , L Adès
- , F Dreyfus
- & P Fenaux
Leukemia 27 , 1283–1290

Rights & permissionsfor article Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents . Opens in a new window.
Research | 12 March 2007
Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation
- A Bergeron
- , A Belle
- , S Chevret
- , P Ribaud
- , A Devergie
- , H Esperou
- , L Ades
- , E Gluckman
- , G Socié
- & A Tazi
Bone Marrow Transplantation 39 , 547–553

Rights & permissionsfor article Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation . Opens in a new window.
26 February 2013
A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)
- V Sardnal
- , A Rouquette
- , S Kaltenbach
- , C Bally
- , V Chesnais
- , C Leschi
- , L Ades
- , V Santini
- , S Park
- , A Toma
- , P Fenaux
- , F Dreyfus
- , M Fontenay
- & O Kosmider
Leukemia 27 , 1610–1613

Rights & permissionsfor article A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q) . Opens in a new window.
Research | 8 January 2007
NF-κB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia
- C Fabre
- , G Carvalho
- , E Tasdemir
- , T Braun
- , L Adès
- , J Grosjean
- , S Boehrer
- , D Métivier
- , S Souquère
- , G Pierron
- , P Fenaux
- & G Kroemer
Oncogene 26 , 4071–4083

Rights & permissionsfor article NF-κB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia . Opens in a new window.
Research | 27 April 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
- S Boehrer
- , L Adès
- , N Tajeddine
- , W K Hofmann
- , S Kriener
- , G Bug
- , O G Ottmann
- , M Ruthardt
- , L Galluzzi
- , C Fouassier
- , M Tailler
- , K A Olaussen
- , C Gardin
- , V Eclache
- , S de Botton
- , S Thepot
- , P Fenaux
- & G Kroemer
Oncogene 28 , 2205–2218

Rights & permissionsfor article Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome . Opens in a new window.
Research | 15 December 2008
ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia
- J Grosjean-Raillard
- , M Tailler
- , L Adès
- , J-L Perfettini
- , C Fabre
- , T Braun
- , S De Botton
- , P Fenaux
- & G Kroemer
Oncogene 28 , 1099–1109

Rights & permissionsfor article ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia . Opens in a new window.
Research | 12 November 2008
Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24–32 mutation
- L Faivre
- , G Collod-Beroud
- , B Callewaert
- , A Child
- , C Binquet
- , E Gautier
- , B L Loeys
- , E Arbustini
- , K Mayer
- , M Arslan-Kirchner
- , C Stheneur
- , A Kiotsekoglou
- , P Comeglio
- , N Marziliano
- , J E Wolf
- , O Bouchot
- , P Khau-Van-Kien
- , C Beroud
- , M Claustres
- , C Bonithon-Kopp
- , P N Robinson
- , L Adès
- , J De Backer
- , P Coucke
- , U Francke
- , A De Paepe
- , G Jondeau
- & C Boileau
European Journal of Human Genetics 17 , 491–501

Rights & permissionsfor article Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24–32 mutation . Opens in a new window.

Refine your results by…

Filters

Filter By:

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

Preclinical modeling of myelodysplastic syndromes

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients

Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS

HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM

Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet

Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia

Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML

Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN?

Hepatic GVHD leading to cirrhosis after allogeneic hematopoietic SCT

Efficacy of lenalidomide in an sAML patient with del 5q relapsing after reduced-intensity allogeneic stem cell transplantation performed in complete remission

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases

Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)

Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation

A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)

NF-κB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia

Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome

ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24–32 mutation

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters